Kimia Biosciences Limited (BOM:530313)

India flag India · Delayed Price · Currency is INR
30.15
-0.11 (-0.36%)
At close: Mar 9, 2026
-34.06%
Market Cap 1.43B
Revenue (ttm) 1.26B
Net Income (ttm) 90.52M
Shares Out 47.31M
EPS (ttm) 1.91
PE Ratio 15.79
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 731
Average Volume 18,904
Open 29.00
Previous Close 30.26
Day's Range 29.00 - 31.49
52-Week Range 26.09 - 86.85
Beta 0.69
RSI 43.71
Earnings Date Feb 14, 2026

About Kimia Biosciences

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its prod... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1993
Employees 250
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530313
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.